71 results about "Hearing disorder" patented technology

Sinusitis, enlarged nasal turbinates, tumors, infections, hearing disorders, allergic conditions, facial fractures and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies, endoscopic studies and transillumination studies. Access and occluder devices may be used to establish fluid tight seals in the anterior or posterior nasal cavities/nasopharynx and to facilitate insertion of working devices (e.g., scopes, guidewires, catheters, tissue cutting or remodeling devices, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting devices, substance delivery implants, etc.

Sinusitis, mucocysts, tumors, infections, hearing disorders, choanal atresia, fractures and other disorders of the paranasal sinuses, Eustachian tubes, Lachrymal ducts and other ear, nose, throat and mouth structures are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies and endoscopic studies. Access and occluding devices may be used to facilitate insertion of working devices such asendoscopes, wires, probes, needles, catheters, balloon catheters, dilation catheters, dilators, balloons, tissue cutting or remodeling devices, suction or irrigation devices, imaging devices, sizing devices, biopsy devices, image-guided devices containing sensors or transmitters, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting or delivering devices and implants, etc.

We disclose a method of treating a patient having a hearing disorder, including coupling at least one electrode to at least one vagus nerve of the patient and applying an electrical signal to the vagus nerve using the electrode to treat the hearing disorder. We also disclose a computer readable program storage device encoded with instructions that, when executed by a computer, perform the method, and a medical device and a hearing disorder treatment system that may be used in performance of the method.

A system for rehabilitation of a hearing disorder which comprises at least one acoustic sensor for picking up an acoustic signal and converting it into an electrical audio signal, an electronic signal processing unit for audio signal processing and amplification, an electrical power supply unit which supplies individual components of the system with current, and an actuator arrangement which is provided with one or more electroacoustic, electromechanical or purely electrical output-side actuators or any combination of these actuators for stimulation of damaged hearing, wherein the signal processing unit has a speech analysis and recognition module and a speech synthesis module.

An at least partially implantable system for rehabilitation of a hearing disorder with at least one acoustic sensor (microphone) for picking up an acoustic sensor signal and converting the acoustic sensor signal into corresponding electrical signals, an electronic signal processing unit for audio signal processing and amplification, an electrical power supply unit which supplies individual components of the system with energy, and an output-side actuator stimulation arrangement, the actuator stimulation arrangement has a dual intracochlear arrangement in combination with a stimulator arrangement with at least one stimulator element for at least indirect mechanical stimulation of a damaged inner ear and one electrically acting stimulation electrode arrangement with at least one cochlear implant electrode for electrical stimulation of the inner ear.

Devices, systems and methods that comprise or utilize implantable electrode arrays for neural stimulation and/or sensing. In some embodiments, the electrode array is implanted or inserted into the auditory nerve and is used to deliver electrical impulses to/receive data from the auditory nerve in the treatment of hearing disorders.

The invention provides a speech enhancing and frequency response compensation fusion method in a digital hearing-aid. The speech enhancing and frequency response compensation fusion method includes the steps of (1) obtaining estimated noise and initial enhanced speech with an MCRA method, respectively carrying out filtering processing on the estimated noise and the initial enhanced speech through a gammatone filter, dividing a signal into M frequency bands through the perception mechanism of the cochleas to the signal, and meanwhile obtaining a time frequency expression mode of the signal, (2) computing masking threshold values of the frequency bands through factors such as the audio masking characteristic of the human ears and the frequency band signal to noise ratios, (3) dynamically computing masking values of noise-contained speech in a time frequency domain through a hearing curve of a hearing disorder patient, and processing speech enhancing and frequency response compensation at the same time, and (4) synthesizing output speech of the heating-aid through the masking values. According to the speech enhancing and frequency response compensation fusion method, the working mechanism of the human ears is sufficiently used, the speech characteristics are kept, music noise introduced through a spectral subtraction method is eliminated, the speech intelligibility of output signals of the hearing-aid is greatly improved, and the low complexity and the low power consumption are achieved.

Methods, devices and systems for improving hearing and for treating hearing disorders, such as auditory neuropathies. A hearing enhancement system of this invention generally comprises; an amplitude modulation processor, a frequency high-pass processor, a frequency upward-shifting processor and a formant upward-shifting processor.

The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizophrenia, substance abuse disorders, sleep disorders or epilepsy.

A sound feedback device comprises a plurality of microphones, a sound source orientation judging unit, a sound volume judging unit, a language to character unit and a situational simulation unit. The sound feedback device can display a virtual compass, sound source orientation, sound volume and character information according to outside sound signals so as to achieve the effect of assisting people having hearing disorder. The invention further provides a working method of the sound feedback device.

The invention discloses a multifunctional synchronous interaction system of music instruments. The multifunctional synchronous interaction system realizes the functions of learning interaction between performers and instruments, rehearsing interaction of multiple performers with the instruments and teaching interaction between special performers with hearing disorder and the instruments. The multifunctional synchronous interaction system comprises an instrument and sensor module, mobile terminal equipment and a projection indicating and executing module. The multifunctional synchronous interaction system controlled by a client software has the advantages that in a way that instrument performing signals are input by multiple sensors, through projection indication of the system, instrument performance and interaction under multiple scene modes are realized, including the scene of performers with hearing disorder, the scene of space division among the performers and the scene of voice rehearsal of multiple performers; the performers can guide the performances of different performers, or guide concerto of multiple performers by teaching on one instrument; or the multifunctional synchronous interaction system realizes learning by teaching or remote interaction, or the performers with hearing disorder can use and learn the instruments to perform.

The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases respiratory conditions and hearing disorders based upon inhibition of the RTP801 gene and/or protein.

Compositions, and methods of use thereof, are provided for the prevention, treatment or alleviation of symptoms of hearing are provided. The methods employ nicergoline, MMDL or MDL as the sole active pharmaceutical agent or a combination of nicergoline, MMDL or MDL and another pharmaceutical agent, such as an antioxidant, a NMDA antagonist, an SSRI or a combined SSRI/NMDA antagonist agent. The method involves the use of nicergoline, MMDL or MDL alone or in combination with another API to prevent, treat or ameliorate one or more symptoms of hearing loss.

The invention belongs to the hearing aid voice quality evaluation technology field and especially relates to a hearing aid voice quality W-PESQ objective evaluation method based on gain compensation. The method comprises steps that firstly, an end point detection method is utilized to carry out alignment processing of a recorded hearing aid output voice signal and an original pure voice signal; signal interception processing on the recorded hearing aid output voice signal and the original pure voice signal after alignment processing is carried out; gain compensation of the pure voice signal without flowing through a hearing aid is carried out; a gain compensation filter is designed, gain adjustment on the original pure voice signal is carried out according to a frequency domain gain curve of the present hearing aid so as to realize fitting of a frequency domain response curve of the gain compensation filter and a gain curve of the hearing aid; lastly, objective evaluation on hearing aid voice quality is carried out through employing a W-PESQ algorithm. The method is advantaged in that a hearing disorder population is considered, the gain compensation filter is designed, through subjective verification, the method has excellent subjective and objective agreement, and great practical values are realized.

The invention provides a music player, relates to the sound wave conversion technique of the music player and belongs to the music player technical field. The music player at least comprises a vibrator and a controller; the controller converts sound wave signals in a digital file into mechanical vibration signals; and the vibrator carries out rhythmic vibration and/or intensive and weak vibration according to the mechanical vibration signals provided by the controller. With the music player of the invention adopted, music transfer can be realized through multi-contact vibration. The music player can be used by people with hearing disorder and can feel the charm of music.

The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases respiratory conditions and hearing disorders based upon inhibition of the RTP801 gene and/or protein.